Evaluation of the effectiveness of the 13-valent pneumococcal conjugate vaccine on pneumococcal serotypes causing pneumonia in children

肺炎链球菌（肺炎球菌）是一种细菌，是世界范围内儿童发病率和死亡率的主要原因。疫苗接种最近被纳入国家免疫规划，以试图解决这一问题。本研究旨在通过使用敏感分子技术分析复杂肺炎患者血液和肺内壁周围液体中的肺炎球菌菌株，通过研究其在预防澳大利亚儿童肺炎方面的有效性来评估新的13价肺炎球菌疫苗。

Streptococcus pneumonia (Pneumococcus) is a bug that is a leading cause of childhood morbidity and mortality world-wide. Vaccinations have been recently brought onto the national immunisation program to try and combat this. This study aims to assess the new 13 valent Pneumococcal vaccine by studying its effectiveness in preventing childhood pneumonia in Australia by analysing the strains of Pneumococus in the blood and the fluid surrounding the lining the lung in complicated pneumonia using sensitive molecular techniques.